Inmunobiología linfocitaria
Universidad del País Vasco/Euskal Herriko Unibertsitatea
Lejona, EspañaPublicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (8)
2024
-
Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1
JHEP Reports, Vol. 6, Núm. 1
2023
-
Mechanical stress confers nuclear and functional changes in derived leukemia cells from persistent confined migration
Cellular and Molecular Life Sciences, Vol. 80, Núm. 11
-
The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895
2022
-
A Potential Role for Bile Acid Signaling in Celiac Disease-Associated Fatty Liver
Metabolites, Vol. 12, Núm. 2
2021
-
Anti-TNFα treatment in Crohn’s disease: Impact on hepatic steatosis, gut-derived hormones and metabolic status
Liver International, Vol. 41, Núm. 11, pp. 2646-2658
-
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma
Hepatology, Vol. 73, Núm. 6, pp. 2380-2396
-
Fat: Quality, or quantity? what matters most for the progression of metabolic associated fatty liver disease (mafld)
Biomedicines, Vol. 9, Núm. 10
2005
-
Herpesvirus saimiri-transformed CD8+ T cells as a tool to study Chediak-Higashi syndrome cytolytic lymphocytes
Journal of Leukocyte Biology, Vol. 77, Núm. 5, pp. 661-668